Mets general manager Sandy Alderson addressed the ongoing controversy over Matt Harvey’s workload this morning. As of now, the plan calls for Harvey to make two more regular season starts and possibly a third one if the Mets need him for the final weekend of the season against the Nationals. This would likely keep him under the much-discussed 180-inning mark.
As for a potential postseason run, Alderson was much more vague this morning, mostly because so much still needs to be decided. Harvey vowed in a piece for the Players’ Tribune yesterday that he will pitch if the Mets make the playoffs, but Bob Nightengale of USA Today hears some details on what his workload could look like:
A person familiar with the Mets’ plans told USA TODAY Sports that after Harvey pitches Tuesday, he would be skipped in his next scheduled start, start one more time and wouldn’t make another regular-season start unless needed on the final weekend of the season against the Nationals. The person spoke on the condition of anonymity because of the sensitive nature of the topic.
And if the Mets make the playoffs, he won’t start more than once during any potential playoff series and perhaps could be limited to no more than 60 pitches in a start.
In other words, his workload would be extremely limited, almost to the point where you question whether it would be worth having him on a postseason roster at all. Mets general manager Sandy Alderson was quick to downplay Nightengale’s report:
We’re still a long way from clarity on this topic. Like it or not, this isn’t going away.
We interrupt your regularly scheduled HBT programming to bring you this breaking news item: The Braves have won a baseball game.
Williams Perez tossed seven strong innings and Hector Olivera hit his first major league home run as the Braves beat the Phillies 7-2 tonight to snap their 12-game losing streak.
Perez allowed two runs on six hits and no walks over his seven innings of work. The rookie right-hander struck out seven batters. Olivera drove in four runs on the night, including a two-run double in the fourth inning and a two-run homer in the ninth. Freddie Freeman also hit a two-run homer in the victory.
This was the Braves’ first win since August 24 and just their second in their last 21 games. As for the Phillies, they have now lost five consecutive games. Tonight’s attendance at Citizens Bank Park (15,125) was the smallest in the history of the ballpark. Tough times for both of these teams.
Blue Jays right-hander Marcus Stroman made his second minor league rehab start today with Triple-A Buffalo and the results weren’t particularly impressive. Making his way back from a torn ACL in his left knee, the 24-year-old gave up four runs on eight hits and four walks over three innings while throwing just 44 out of 79 pitches for strikes.
While the results weren’t there, Stroman told Arden Zwelling of Sportsnet.ca that he felt great physically and is ready to contribute in the majors.
“My arm felt great, knee felt great. The results didn’t say so but my stuff felt unreal,” Stroman said. “I know people are going to say, ‘oh, he didn’t have a good start.’ But stuff-wise, arm-wise, knee-wise, health-wise—I’m ready to go.”
The next step for Stroman is up in the air. He has been talked about to start Saturday in a big series against the Yankees, but nothing is official yet. Mark Buehrle is the other option to start Saturday, but he had his shortest start of the season this afternoon against the Red Sox and has been dealing with some unspecified “aches and pains” of late. For what it’s worth, the veteran southpaw has also historically struggled at the new Yankee Stadium. There’s some risk either way, but Shi Davidi of Sportsnet.ca writes that the Blue Jays may be leaning toward going with Stroman and pushing back Buehrle.
Stroman was considered a breakout candidate for many this spring after posting a 3.65 ERA and 111/28 K/BB ratio in 130 2/3 innings over 20 starts and six relief appearances as a rookie in 2014. The Blue Jays are already looking dangerous, but a healthy and effectiveness Stroman could make them even better.